#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians treating older adults need to understand that edible cannabis use in this population is increasing, which requires screening for potential drug interactions with common medications like anticoagulants and sedatives that older patients frequently take. Edibles present distinct risks compared to other cannabis forms, including delayed onset of effects that may lead to overdosing and metabolic interactions through hepatic processing that may be impaired in elderly patients. Providers should incorporate cannabis use into medication histories and counsel older patients on the pharmacokinetic differences of edibles to prevent adverse events and optimize treatment safety.
A recent study from University of Utah Health and University of Colorado Boulder reports an increasing trend of cannabis edible use among older adults, a population historically underrepresented in cannabis research and clinical literature. This shift toward edibles rather than inhalation methods is clinically significant because it may reduce respiratory risks associated with smoking, though edibles present distinct pharmacokinetic challenges including delayed onset, variable absorption, and prolonged effects that older adults may not anticipate. Clinicians should recognize that older patients are actively using cannabis products, often for symptom management related to pain, sleep, or anxiety, yet may not disclose this use without direct inquiry due to generational stigma or lack of awareness about drug interactions. The popularity of edibles in this demographic raises particular concerns about accidental overdosing, cognitive impairment, and falls in a population already at higher risk for adverse outcomes. Clinicians caring for older adults should proactively screen for cannabis use, educate patients about edible-specific risks including delayed effects and prolonged duration, and remain informed about potential interactions with common medications in this age group. Practitioners should ask older patients directly about cannabis use and provide evidence-based counseling on safer consumption methods and dosing strategies if the patient chooses to continue use.
“What I’m seeing clinically is that older adults are increasingly using edibles because they avoid respiratory irritation, but they often underestimate the delayed onset and longer duration compared to smoking, which leads to accidental overconsumption and preventable adverse events like falls and delirium that I could avoid with proper dosing education.”
💊 The rising use of cannabis edibles among older adults represents an emerging clinical phenomenon that warrants attention in primary care and geriatric medicine. While some patients may perceive edibles as a safer alternative to smoking for managing pain, anxiety, or sleep disturbances, clinicians should recognize that this population faces particular risks including delayed onset of effects leading to accidental overdosing, increased fall risk, cognitive effects, and potential drug interactions with common medications like anticoagulants and sedatives. The heterogeneity of edible products, variable THC and CBD concentrations, and limited high-quality evidence in older populations create substantial uncertainty about appropriate dosing and long-term safety. Healthcare providers should proactively ask older patients about cannabis use during medication reviews and substance use screening, counsel patients on the risks of edibles specifically, and document use in the medical record to identify potential interactions. For patients interested in cannabis for symptom management, a shared decision
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
